From Berkeley Lovelace Jr.:
Category: NYSE:PJP
Will Pharmaceutical ETFs Continue To Rally This Holiday Season? (PJP)
From Zacks: As we head toward the end of 2017, the pharma sector continues to perform well, representing a contrast to 2016 when the sector was under immense pressure due to the drug pricing issue.
It Might Be Time To Buy Pharmaceuticals (PJP)
From Invesco: The pharmaceutical industry has lagged in recent years, due in part to political uncertainty, which has kept a lid on company share prices.
Pharmaceuticals (PJP) Won’t Be The Only Sector Hurt By Legal Pot
From Bill Hall: In my most recent Money and Markets articles, I’ve put you on the inside track about a rapidly growing, yet mostly still under-the-radar, industry. One that the world’s super-rich are quietly funding with their own money, in pursuit of potentially eye-popping investment returns.
Time To Buy Pharmaceutical ETFs?
From Zacks: 2016 turned out to be a challenging year for pharma stocks with the sector facing a lot of criticism for rising drug prices. Although the election results provided a breather for the sector on hopes that drug pricing would not be a key focus area under a Donald Trump presidency, the relief rally […]
Pharma ETFs In Focus As Washington Debates Prescription Drug Pricing
With all of the talk from Capitol Hill in regards to prescription pill prices and proposed healthcare reform, today we hone in on the Pharmaceutical segment within the greater Healthcare industry sector in ETF land.
Trump’s War On Drug Prices Not The Only Concern For Pharma Companies
From Brad Hoppmann: The news out of Washington keeps flooding out, and specifically news that’s being made straight from the Oval Office.
Are Pharmaceutical Stocks In Trouble?
From Dana Lyons: The post-2009 bull market in drug stocks is currently being threatened, with a key index reaching a critical technical level.
ETFs To Watch On Solid Pharma Earnings [Market Vectors Pharmaceutical ETF, iShares Dow Jones US Pharm Indx (ETF)]
NYSEARCA:PPH, NYSEARCA:IHE
A Beaten-Up Pharma With a Big Upside [The Medicines Company(NASDAQ:MDCO), Pfizer Inc.(NYSE:PFE), Merck & Co., Inc.(NYSE:MRK)]
NASDAQ:MDCO, NYSE:PFE, NYSE:MRK
ETF Impact On Biotech Earnings [Celgene Corporation, Alexion Pharmaceuticals, Inc., Amgen, Inc., Biogen Idec Inc]
NASDAQ:CELG, NASDAQ:ALXN, NASDAQ:BIIB, NASDAQ:AMGN
ETFs To Watch On Strong Earnings From Pharma Companies [Pfizer Inc., Merck & Co., Inc., Eli Lilly and Co]
NYSE:PFE, NYSE:MRK, NYSE:LLY
ETFs To Cash In On Aging Global Population [SPDR KBW Capital Markets (ETF), Vanguard Dividend Appreciation ETF]
NYSEARCA:KCE, NYSEARCA:VIG
ETFs To Watch As Obamacare Hits Deadline [PowerShares Dynamic Pharmaceuticals(ETF), SPDR S&P Biotech (ETF)]
NYSEARCA:XBI, NYSEARCA:PJP
Top Pharmaceutical ETFs To Consider [Biogen Idec Inc, SPDR S&P Pharmaceuticals (ETF), Health Care SPDR (ETF)]
NASDAQ:BIIB, NYSEARCA:XPH, NYSEARCA:IHE, NYSEARCA:PJP, NYSEARCA:XLV